October 30, 2014
Ultragenyx Granted EU Orphan Drug Designation for KRN23 for the Treatment of X-Linked Hypophosphatemia
Media
October 30, 2014
Positive Phase II preliminary results of Validive® for the prevention of Severe Oral Mucositis in Head and Neck cancer patients
October 30, 2014
Cortendo Announces HealthCap Leads $11M (NOK 73.4M) Private Placement
October 23, 2014
Nordic Nanovector AS: Third quarter report 2014
October 23, 2014
HealthCap i unikt samarbetsprojekt “Agenda för hälsa och välstånd”
October 22, 2014
Interim report January-September 2014
October 15, 2014
Orexo appoints Nomination Committee and publishes financial calendar 2014/2015
October 13, 2014
Nexstim launches its Initial Public Offering and will apply for dual listing on Nasdaq First North Finland and Nasdaq First North Sweden
October 13, 2014
Orexo submits application to FDA for expanded label of ZUBSOLV®
October 02, 2014
Nexstim Supports 6th International Symposium on Navigated Brain Stimulation in Neurosurgery